Gerard Espinosa, Ricard Cervera. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anti-Inflammatory Agents/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAntigens, CD/immunologyHumansImmunologic Factors/therapeutic useImmunosuppressive Agents/therapeutic useLupus Erythematosus, Systemic/drug therapyLupus Erythematosus, Systemic/immunologyRituximabTakayasu Arteritis/drug therapyTakayasu Arteritis/immunologyVasculitis/drug therapyVasculitis/immunology
Substances: See more » Anti-Inflammatory AgentsAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntigens, CDImmunologic FactorsImmunosuppressive AgentsRituximab
Year: 2007 PMID: 17408539 DOI: 10.1157/13100566
Source DB: PubMed Journal: Med Clin (Barc) ISSN: 0025-7753 Impact factor: 1.725